### Comment:
It dropped 100$ back in March, which seems to line up with when they halted the study claiming it wasn't possible for endpoints to be achieved or something, is this inaccurate?

### REPLY:
No completely accurate and the stock dropped like 5% or so. Basically they halted the study and reviewed the data more. Then they somehow came to the conclusion that it may work. So they restarted it.

### END.